Altman Advisors, Inc. Eli Lilly & CO Transaction History
Altman Advisors, Inc.
- $249 Million
- Q4 2024
A detailed history of Altman Advisors, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Altman Advisors, Inc. holds 675 shares of LLY stock, worth $569,882. This represents 0.21% of its overall portfolio holdings.
Number of Shares
675
Previous 1,608
58.02%
Holding current value
$569,882
Previous $1.42 Million
63.41%
% of portfolio
0.21%
Previous 0.63%
Shares
2 transactions
Others Institutions Holding LLY
# of Institutions
4,229Shares Held
755MCall Options Held
9.22MPut Options Held
10.9M-
Lilly Endowment Inc Indianapolis, IN96.9MShares$81.8 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA74.2MShares$62.7 Billion1.03% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$55.6 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.3MShares$43.3 Billion26.72% of portfolio
-
State Street Corp Boston, MA34.3MShares$29 Billion1.07% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $802B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...